Multi-targeted therapy with a HER-2/neu-specific vaccine and a VEGF-R2 inhibitor enhances anti-tumor immunity
Year: 2006
Type: article
Source: Cancer Research
Institution: Johns Hopkins University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2113261280
